1. 1859 Clinical effects of prior chemotherapy on eribulin: Update and subgroup analysis of phase 2 multicenter single arm study of eribulin mesylate as first-line therapy for HER2 negative locally advanced or metastatic breast cancer. (September 2015) Authors: Nishimura, S.; Takashima, T.; Kawajiri, H.; Kashiwagi, S.; Noda, S.; Tokunaga, S.; Tei, S.; Yamagata, S.; Sunami, T.; Tezuka, K.; Ikeda, K.; Mizuyama, Y.; Ogawa, Y.; Onoda, N.; Nishimori, T.; Ishikawa, T.; Kudo, S.; Takada, M.; Hirakawa, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2824 Efficacy of B-raf and MEK inhibitor on human anaplastic thyroid cancer cell lines. (September 2015) Authors: Kurata, K.; Onoda, N.; Noda, S.; Kashiwagi, S.; Asano, Y.; Takashima, T.; Hirakawa, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 530 A phase II study of cancer vaccination using three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study). (September 2015) Authors: Iguchi, H.; Suzuki, N.; Uesugi, K.; Tanaka, H.; Hirakawa, K.; Aruga, A.; Hatori, T.; Ishizaki, H.; Umeda, Y.; Fujiwara, T.; Shimada, M.; Ikemoto, T.; Yoshimatsu, K.; Shimizu, R.; Hayashi, H.; Sakata, K.; Yoshino, S.; Furukawa, H.; Hazama, S.; Oka, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An exploratory phase II study of Eribulin re-challenge after short term therapy of 5-fuluorouracil for HER2-negative, advanced or recurrent breast cancer. (October 2020) Authors: Takashima, T.; Nishimura, S.; Kawajiri, H.; Mizuyama, Y.; Nishimori, T.; Yamagata, S.; Tokunaga, S.; Tezuka, K.; Tei, S.; Sunami, T.; Ikeda, K.; Ogawa, Y.; Kashiwagi, S.; Noda, S.; Onoda, N.; Ishikawa, T.; Kudoh, S.; Takada, M.; Hirakawa, K.; Ohira, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. C‐Kit expression as a prognostic molecular marker in patients with basal‐like breast cancer. Issue 4 (14th January 2013) Authors: Kashiwagi, S.; Yashiro, M.; Takashima, T.; Aomatsu, N.; Kawajiri, H.; Ogawa, Y.; Onoda, N.; Ishikawa, T.; Wakasa, K.; Hirakawa, K. Journal: British journal of surgery Issue: Volume 100:Issue 4(2013:Apr.) Page Start: 490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Janus organic semiconductor nanoparticles prepared by simple nanoprecipitation. (December 2022) Authors: Holmes, A.; Laval, H.; Schmutz, M.; Blanc, S.; Allouche, J.; Watts, B.; Wantz, G.; Holmes, N.P.; Hirakawa, K.; Deniau, E.; Chambon, S.; Lartigau-Dagron, C.; Bousquet, A. Journal: Materials today chemistry Issue: Volume 26(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Issue 8 (26th May 2015) Authors: Tokunaga, T.; Sakashita, M.; Haruna, T.; Asaka, D.; Takeno, S.; Ikeda, H.; Nakayama, T.; Seki, N.; Ito, S.; Murata, J.; Sakuma, Y.; Yoshida, N.; Terada, T.; Morikura, I.; Sakaida, H.; Kondo, K.; Teraguchi, K.; Okano, M.; Otori, N.; Yoshikawa, M. Journal: Allergy Issue: Volume 70:Issue 8(2015:Aug.) Page Start: 995 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-045The pretreatment Controlling Nutritional Status (CONUT) score as an independent prognostic factor in patients with clinical Stage I-III esophageal squamous cell carcinoma. (24th June 2015) Authors: Toyokawa, T.; Kubo, N.; Shibutani, M.; Sakurai, K.; Nagahara, H.; Tanaka, H.; Muguruma, K.; Ohtani, H.; Yashiro, M.; Maeda, K.; Ohira, M.; Hirakawa, K. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 4 Page Start: iv12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY. (23rd June 2022) Authors: Mizuhara, K.; Kobayashi, T.; Nakao, M.; Takahashi, R.; Kaneko, H.; Shimura, K.; Hirakawa, K.; Uoshima, N.; Kamitsuji, Y.; Wada, K.; Kawata, E.; Isa, R.; Fujino, T.; Matsumura-Kimoto, Y.; Tsukamoto, T.; Mizutani, S.; Shimura, Y.; Taniwaki, M.; Kuroda, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prognostic value of quality‐of‐life scores in patients with breast cancer undergoing preoperative chemotherapy. Issue 1 (26th November 2018) Authors: Takada, K.; Kashiwagi, S.; Fukui, Y.; Goto, W.; Asano, Y.; Morisaki, T.; Takashima, T.; Hirakawa, K.; Ohira, M. Journal: BJS open Issue: Volume 3:Issue 1(2019) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗